List view / Grid view
The precision of data from surface plasmon resonance (SPR)-based analyses, and the confidence with which results can be interpreted, is strongly coupled to the sensitivity of the SPR sensor. Biacore™ T200 system from GE Healthcare offers excellent sensitivity that enables detection of the lowest molecular-weight interactions and accurate measurements at…
This free-to-view Screening In-Depth Focus is packed with articles that will give you a greater understanding of interesting topics such as the identification of compounds that protect against free radicals, advancements in sandwich immunoassay techniques and hit validation and optimisation...
11 September 2014 | By Advanced Accelerator Applications and GE Healthcare
Advanced Accelerator Applications strengthens its position in the Italian PET Radiopharmaceutical Market...
21 February 2013 | By Sheraz Gul, Head of Biology at European ScreeningPort, Hamburg, Germany
Recent years have witnessed an expansion in the disciplines encompassing drug discovery outside the pharmaceutical industry. This is most notable with a significant number of universities worldwide that now host infrastructure such as compound libraries and automated screening centres[1-3]. An archetypal small molecule drug discovery project will aim to identify…
18 December 2012 | By Merck
Clinical study collaboration announced...
20 June 2011 | By Fredrik Sundberg, Global Director, Strategic Market Development, GE Healthcare
As a company whose expertise includes medical imaging and information technologies, performance improvement and biopharmaceutical manufacturing, GE Healthcare is well placed to support drug discovery innovation and productivity. With the Pharma industry moving away from blockbuster discoveries and focusing more on orphan drugs and rare diseases in the hopes of…
28 April 2011 | By College Hill Ltd
GE Healthcare, today announced it has reached an agreement to acquire Applied Precision, Inc...
24 February 2011 | By GE Healthcare
Kieran Murphy will be promoted to succeed current Life Sciences President and CEO...
18 February 2011 | By GE Healthcare
Kieran Murphy succeeds retiring Peter Ehrenheicurrent as Life Sciences President and CEO on 31 July 2011...
1 December 2010 | By Johnson & Johnson
Janssen announced a research agreement to collaborate with GE Healthcare...
30 June 2010 | By kdm communications limited
Registration for the second annual WIN Symposium on personalized cancer medicine is still open, with a preferential rate available until the 4th of July...
22 February 2010 | By
It would be fair to say that these past 12 months have been a watershed year for stem cell science. In years to come we may look back on 2009 and recognise it as the year in which nascent areas of science, medicine and technology came together to slowly nudge…
